Cefaxam® 500/250 Each vial containing powder holds:

Ceftriaxone Sodium (equiv. to Ceftriaxone).............................................. 500 mg

Sulbactam Sodium (equiv. to Sulbactam)................................................ 250 mg

Each vial containing diluent holds:

Sterile diluent ………………………………………………...................................... 10 mL

Cefaxam® is indicated for infections caused by pathogens susceptible to ceftriaxone and sulbactam, including beta-lactamase producers. This combination is indicated for:

- Intra-abdominal infections (peritonitis, biliary tract infections); bone and joint, soft tissue, and skin infections; meningitis; renal and genitourinary tract infections; respiratory tract infections (particularly pneumonia); mastitis; ear, nose, and throat infections; and bacterial septicemia.

- Perioperative infection prophylaxis. A single dose administered prior to surgery minimizes the risk of postoperative infection.

- Complicated infections caused by multidrug-resistant pathogens, including strains producing beta-lactamases and metallo-beta-lactamases.

- Lyme disease (borreliosis) caused by Borrelia burgdorferi.